2H

H&R GmbH & Co KgaAXETRA H&R & Stock Report

Last reporting period 30 Jun, 2024

Updated 01 Nov, 2024

Last price

Market cap $B

0.158

Micro

Exchange

XETR - Xetra

2HRA.DE Stock Analysis

2H

Avoid

Based on Eyestock quantitative analysis, 2HRA.DE`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

40/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-41.0 %

Overvalued

Market cap $B

0.158

Dividend yield

2.02 %

Shares outstanding

37.222 B

H&R GmbH & Co. KGaA is a holding company, which engages in the manufacture of mineral oil specialties. The company is headquartered in Salzbergen, Niedersachsen. The company operates through three segments: Chemical-Pharmaceutical Raw Materials Refining (ChemPharm Refining), Chemical-Pharmaceutical Raw Materials Sales (ChemPharm Sales) and Plastics. The ChemPharm Refining segment comprises two refineries in Germany, which produce plasticizers, paraffins, white oils and base oils; the ChemPharm Sales segment includes production and distribution sites worldwide and its main products are label-free plasticizers for the tire industry, as well as paraffins for various applications, and the Plastics segment produces precision plastic parts and molding tools to manufacture precision plastic parts.

View Section: Eyestock Rating